🚀 VC round data is live in beta, check it out!
Avanos Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Avanos Medical and similar public comparables like Dynavox Group, Mani Inc., Conmed, Anbio Biotechnology and more.
Avanos Medical Overview
About Avanos Medical
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
Founded
2014
HQ
Employees
2.3K
Website
Financials (LTM)
EV
$1B
Avanos Medical Financials
Avanos Medical reported last 12-month revenue of $704M and EBITDA of $88M.
In the same LTM period, Avanos Medical generated $381M in gross profit, $88M in EBITDA, and $44M in net income.
Revenue (LTM)
Avanos Medical P&L
In the most recent fiscal year, Avanos Medical reported revenue of $701M and EBITDA of $87M.
Avanos Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $704M | XXX | $701M | XXX | XXX | XXX |
| Gross Profit | $381M | XXX | $354M | XXX | XXX | XXX |
| Gross Margin | 54% | XXX | 50% | XXX | XXX | XXX |
| EBITDA | $88M | XXX | $87M | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $44M | XXX | $43M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $11M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Avanos Medical Stock Performance
Avanos Medical has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Avanos Medical's stock price is $24.62.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | 0.0% | XXX | XXX | XXX | $0.93 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAvanos Medical Valuation Multiples
Avanos Medical trades at 1.7x EV/Revenue multiple, and 13.5x EV/EBITDA.
EV / Revenue (LTM)
Avanos Medical Financial Valuation Multiples
As of April 20, 2026, Avanos Medical has market cap of $1B and EV of $1B.
Equity research analysts estimate Avanos Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Avanos Medical has a P/E ratio of 25.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 13.5x | XXX | 13.7x | XXX | XXX | XXX |
| EV/EBIT | 17.6x | XXX | 17.7x | XXX | XXX | XXX |
| EV/Gross Profit | 3.1x | XXX | 3.4x | XXX | XXX | XXX |
| P/E | 25.9x | XXX | 26.5x | XXX | XXX | XXX |
| EV/FCF | 27.6x | XXX | 27.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Avanos Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Avanos Medical Margins & Growth Rates
Avanos Medical's revenue in the last 12 month grew by 2%.
Avanos Medical's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Avanos Medical's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Avanos Medical's rule of X is 16% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Avanos Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 48% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Avanos Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Avanos Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Dynavox Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Mani Inc. | XXX | XXX | XXX | XXX | XXX | XXX |
| Conmed | XXX | XXX | XXX | XXX | XXX | XXX |
| Anbio Biotechnology | XXX | XXX | XXX | XXX | XXX | XXX |
| Shanghai Haohai | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Avanos Medical M&A Activity
Avanos Medical acquired XXX companies to date.
Last acquisition by Avanos Medical was on XXXXXXXX, XXXXX. Avanos Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Avanos Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAvanos Medical Investment Activity
Avanos Medical invested in XXX companies to date.
Avanos Medical made its latest investment on XXXXXXXX, XXXXX. Avanos Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Avanos Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Avanos Medical
| When was Avanos Medical founded? | Avanos Medical was founded in 2014. |
| Where is Avanos Medical headquartered? | Avanos Medical is headquartered in United States. |
| How many employees does Avanos Medical have? | As of today, Avanos Medical has over 2K employees. |
| Who is the CEO of Avanos Medical? | Avanos Medical's CEO is David C. Pacitti. |
| Is Avanos Medical publicly listed? | Yes, Avanos Medical is a public company listed on NYSE. |
| What is the stock symbol of Avanos Medical? | Avanos Medical trades under AVNS ticker. |
| When did Avanos Medical go public? | Avanos Medical went public in 2014. |
| Who are competitors of Avanos Medical? | Avanos Medical main competitors are Dynavox Group, Mani Inc., Conmed, Anbio Biotechnology. |
| What is the current market cap of Avanos Medical? | Avanos Medical's current market cap is $1B. |
| What is the current revenue of Avanos Medical? | Avanos Medical's last 12 months revenue is $704M. |
| What is the current revenue growth of Avanos Medical? | Avanos Medical revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Avanos Medical? | Current revenue multiple of Avanos Medical is 1.7x. |
| Is Avanos Medical profitable? | Yes, Avanos Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Avanos Medical? | Avanos Medical's last 12 months EBITDA is $88M. |
| What is Avanos Medical's EBITDA margin? | Avanos Medical's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Avanos Medical? | Current EBITDA multiple of Avanos Medical is 13.5x. |
| What is the current FCF of Avanos Medical? | Avanos Medical's last 12 months FCF is $43M. |
| What is Avanos Medical's FCF margin? | Avanos Medical's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Avanos Medical? | Current FCF multiple of Avanos Medical is 27.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.